Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown

Arthritis and Rheumatism

Volumn 44, Issue 7, 2001, Pages 1620-1632

  Rowan, A D ^a,f   Koshy, P J T ^a   Shingleton, W D ^a   Degnan, B A ^a   Heath, J K ^b   Vernallis, A B ^c   Spaull, J R ^d   Life, P F ^d   Hudson, K ^e   Cawston, T E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c ASTON UNIVERSITY   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

^e Genesis Research & Development Corporation Ltd   (New Zealand)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; COLLAGEN; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LEUKEMIA INHIBITORY FACTOR RECEPTOR; MESSENGER RNA; ONCOSTATIN M; PROTEOGLYCAN;

ARTICLE; BIOASSAY; CARTILAGE CELL; COLLAGEN DEGRADATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPLANT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS;

ANIMALS; ANTIGENS, CD; CARTILAGE, ARTICULAR; CATTLE; CELL LINE, TRANSFORMED; CHONDROCYTES; CILIARY NEUROTROPHIC FACTOR; COLLAGEN; CYTOKINE RECEPTOR GP130; CYTOKINES; DRUG SYNERGISM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-11; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MATRIX METALLOPROTEINASE 1; MEMBRANE GLYCOPROTEINS; ONCOSTATIN M; PEPTIDES; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0034944224     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B     Document Type: Article

References (77)

1. Matrix metalloproteinases and TIMPs: Properties and implications for the rheumatic diseases
2. In vivo studies of articular tissue damage mediated by catabolin/interleukin-1
3. In vivo studies of cartilage regeneration after damage induced by catabolin/interleukin-1
4. The breakdown of collagen by chondrocytes
5. Human skin collagenase: Isolation of precursor and active forms from both fibroblast and organ cultures
6. Human neutrophil collagenase: A distinct gene product with homology to other matrix metalloproteinases
7. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas
8. gp130 and the interleukin-6 family of cytokines
9. Oncostatin M and leukemia inhibitor factor trigger overlapping and different signals through partially shared receptor complexes
10. Dual oncostatin M (OSM) receptors: Cloning and characterization of an alternative signalling subunit conferring OSM-specific receptor activation
11. Interleukin-1 and oncostatin M in combination promote the release of collagen fragments from bovine nasal cartilage in culture
12. The role of oncostatin M in animal and human connective tissue collagen turnover and its localization within the rheumatoid joint
13. Synovial fluid concentrations of five different cytokines in rheumatic diseases
14. Overexpression of mouse oncostatin M in joints by adenovirus vector causes pannuslike alterations in synovium of mice
15. Amelioration of arthritis in two murine models using antibodies to oncostatin M
16. Interleukin-6 and its receptor: A paradigm for cytokines
17. Impaired immune and acute-phase responses in interleukin-6-deficient mice
18. Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
19. Interleukin-6 levels in synovial fluids of patients with different arthritides: Correlation with local IgM rheumatoid factor and systemic acute phase protein production
20. Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis
21. Interleukin-6 (IL-6) induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor
22. Generation of 'truncated' interleukin-6 receptor (IL-6R) mRNA by alternative splicing: A possible source of soluble IL-6R
23. 2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells
24. C-reactive protein: A physiological activator of interleukin-6 receptor shedding
25. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis
26. Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 in rat osteoblast cultures
27. Interleukin (IL)-6 and its soluble receptor induce TIMP-1 expression in synoviocytes and chondrocytes, and block IL-1-induced collagenolytic activity
28. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
29. Interleukin-6 reduces cartilage destruction during experimental arthritis: A study in interleukin-6-deficient mice
30. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis
31. Interleukin-1β-modulated gene expression in immortalized human chondrocytes
32. The interactions of the cytokine-binding homology region and immunoglobulin-like domains of gp130 with oncostatin M: Implications for receptor complex formation
33. The crystal structure and biological function of leukemia inhibitory factor: Implications for receptor binding
34. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family
35. The prevention of collagen breakdown in bovine nasal cartilage by TIMP, TIMP-2 and a low molecular weight synthetic inhibitor
36. Transforming growth factor-beta causes the partial inhibition of interleukin 1-stimulated cartilage degradation in vitro
37. All-trans-retinoic acid interacts synergistically with basic fibroblast growth factor and epidermal growth factor to stimulate the production of tissue inhibitor of metalloproteinases from fibroblasts
38. The effect of retinoic acid in combination with PDGF-BB or TGF-β on TIMP and collagenase secretion from human skin and synovial fibroblasts
39. Differential effects of bFGF and IGF-1 on matrix metabolism in calf and adult bovine cartilage experiments
40. Insulin-like growth factor 1 can decrease degradation and promote synthesis of proteoglycan in cartilage exposed to cytokines
41. Insulin-like growth factors maintain steady-state metabolism of proteoglycans in bovine articular cartilage explants
42. The effect of serum on biosynthesis of proteoglycans by bovine articular cartilage in culture
43. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue
44. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline
45. Monoclonal antibodies against human fibroblast collagenase and the design of an enzyme-linked immunosorbent assay to measure total collagenase
46. 3H] acetylated collagen
47. A rapid and reproducible assay for collagenase using [1-14C] acetylated collagen
48. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants
49. Signaling of type II oncostatin M receptor
50. Computational EST database analysis identifies a novel member of the neuropoietic cytokine family
51. Novel neurotprophin-1/B cell stimulating factor-3: A cytokine of the IL-6 family
52. Selective regulation of metalloproteinase inhibitor (TIMP-1) by oncostatin M in fibroblasts in culture
53. Autocrine/paracrine induction of tissue inhibitor of metalloproteinase-1 in Chinese hamster ovary cells by oncostatin M
54. Stimulation of TIMP-1 production by oncostatin M in human articular cartilage
55. Oncostatin M is a proinflammatory mediator: In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules
56. Nucleotide sequence of bovine interleukin-6 cDNA
57. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP13)
58. Cloning, sequencing and characterization of the 5′-flanking region of the human collagenase-3 gene
59. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression
60. Interleukin-6 increases rat metalloproteinase-13 gene expression through stimulation of activator protein 1 transcription factor in cultured fibroblasts
61. Oncostatin M stimulates c-fos to bind a transcriptionally responsive AP-1 element within the tissue inhibitor of metalloproteinase-1 promoter
62. The AP-1 site and MMP gene regulation: What is all the fuss about?
63. Two activator protein-1 elements in the matrix metalloproteinase-1 promoter have differential effects on transcription and bind Jun D, c-Fos, and Fra-2
64. Jaks and Stats in signaling by the cytokine receptor superfamily
65. Oncostatin M up-regulates tissue inhibitor of metalloproteinases-3 gene expression in articular chondrocytes via de novo transcription, protein synthesis, and tyrosine kinaseand mitogen-activated protein kinase-dependent mechanisms
66. gp130 is involved in stretch-induced MAP kinase activation in cardiac myocytes
67. IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase
68. Transforming growth factor-β1 blocks the release of collagen fragments from bovine nasal cartilage stimulated by oncostatin M in combination with interleukin-1α
69. Oncostatin M stimulates urokinase-type plasminogen activator activity in human synovial fibroblasts
70. Interleukin 6 is required for the development of collagen-induced arthritis
71. Interleukin 6 plays a key role in the development of antigen-induced arthritis
72. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses
73. Treatment of severe rheumatoid arthritis by anti-interleukin-6 monoclonal antibody
74. Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody
75. Human cardiotrophin-1: Protein and gene structure, biological and binding activities, and chromosomal location
76. Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130
77. Regulation of the type II oncostatin M receptor expression in lung-derived epithelial cells